Of marsupials and men: “Backdoor” dihydrotestosterone synthesis in male sexual differentiation

Andersson, 1996, Molecular genetics and pathophysiology of 17 beta-hydroxysteroid dehydrogenase 3 deficiency, J. Clin. Endocrinol. Metab., 81, 130 Auchus, 1998, Cytochrome b5 augments the 17,20-lyase activity of human P450c17 without direct electron transfer, J. Biol. Chem., 273, 3158, 10.1074/jbc.273.6.3158 Auchus, 2001, The genetics, pathophysiology, and management of human deficiencies of P450c17, Endocrinol. Metab. Clin. North Am., 30, 101, 10.1016/S0889-8529(08)70021-5 Auchus, 2004, The backdoor pathway to dihydrotestosterone, Trends Endocrinol. Metab., 15, 432, 10.1016/S1043-2760(04)00214-0 Baser, 2006, The distribution of constitutional and somatic mutations in the neurofibromatosis 2 gene, Hum. Mutat., 27, 297, 10.1002/humu.20317 Biason-Lauber, 2010, Control of sex development, Best Pract. Res. Clin. Endocrinol. Metab., 24, 163, 10.1016/j.beem.2009.12.002 Biswas, 1997, Expression cloning and characterization of oxidative 17β- and 3α-hydroxysteroid dehydrogenases from rat and human prostate, J. Biol. Chem., 272, 15959, 10.1074/jbc.272.25.15959 Bose, 1996, The pathophysiology and genetics of congenital lipoid adrenal hyperplasia, N. Engl. J. Med., 335, 1870, 10.1056/NEJM199612193352503 Couture, 2005, Comparison of crystal structures of human type 3 3α-hydroxysteroid dehydrogenase reveals an “induced-fit” mechanism and a conserved basic motif involved in the binding of androgen, Protein Sci., 14, 1485, 10.1110/ps.051353205 Dufort, 1996, Molecular cloning of human type 3 3 α -hydroxysteroid dehydrogenase that differs from 20 α -hydroxysteroid dehydrogenase by seven amino acids, Biochem. Biophys. Res. Commun., 228, 474, 10.1006/bbrc.1996.1684 Dufort, 2001, Human types 1 and 3 3 α -hydroxysteroid dehydrogenases: differential lability and tissue distribution, J. Clin. Endocrinol. Metab., 86, 841 Eckstein, 1987, Production of testosterone from progesterone by rat testicular microsomes without release of the intermediates 17 alpha-hydroxyprogesterone and androstenedione, Eur. J. Biochem., 166, 425, 10.1111/j.1432-1033.1987.tb13533.x Flück, 2003, The 17,20-lyase activity of cytochrome P450c17 from human fetal testis favors the Δ5 steroidogenic pathway, J. Clin. Endocrinol. Metab., 88, 3762, 10.1210/jc.2003-030143 Flück, 2011, Why boys will be boys: two pathways of fetal testicular androgen biosynthesis are needed for male sexual differentiation, Am. J. Hum. Genet., 89, 201, 10.1016/j.ajhg.2011.06.009 French, 1990, Molecular basis of androgen insensitivity, Recent Prog. Horm. Res., 46, 1 Geissler, 1994, Male pseudohermaphroditism caused by mutations of testicular 17 beta-hydroxysteroid dehydrogenase 3, Nat. Genet., 7, 34, 10.1038/ng0594-34 Goto, 2006, In humans, early cortisol biosynthesis provides a mechanism to safeguard female sexual development, J. Clin. Invest., 116, 953, 10.1172/JCI25091 Grumbach, 2003, Disorders of sex differentiation, 42 Gupta, 2003, 5alpha-reduced C21 steroids are substrates for human cytochrome P450c17, Arch. Biochem. Biophys., 418, 151, 10.1016/j.abb.2003.07.003 Jin, 2006, Multiple steps determine the overall rate of the reduction of 5 α -dihydrotestosterone catalyzed by human type 3 3 α -hydroxysteroid dehydrogenase: implications for the elimination of androgens, Biochemistry, 45, 13054, 10.1021/bi060591r Kim, 2008, Severe combined adrenal and gonadal deficiency caused by novel mutations in the cholesterol side chain cleavage enzyme, P450scc, J. Clin. Endocrinol. Metab., 93, 696, 10.1210/jc.2007-2330 Lin, 1997, Expression and characterization of recombinant type 2 3 α -hydroxysteroid dehydrogenase (HSD) from human prostate: demonstration of bifunctional 3 α /17β-HSD activity and cellular distribution, Mol. Endocrinol., 11, 1971 MacLaughlin, 2004, Sex determination and differentiation, N. Engl. J. Med., 350, 367, 10.1056/NEJMra022784 Mahendroo, 2004, Steroid 5 α -reductase promotes 5 α -androstane-3 α, 17β-diol synthesis in immature mouse testes by two pathways, Mol. Cell. Endocrinol., 222, 113, 10.1016/j.mce.2004.04.009 McPhaul, 1993, Genetic basis of endocrine disease. 4. The spectrum of mutations in the androgen receptor gene that causes androgen resistance, J. Clin. Endocrinol. Metab., 76, 17 Miller, 2011, The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders, Endocr. Rev., 32, 81, 10.1210/er.2010-0013 Moisan, 1999, New insight into the molecular basis of 3beta-hydroxysteroid dehydrogenase deficiency: identification of eight mutations in the HSD3B2 gene eleven patients from seven new families and comparison of the functional properties of twenty-five mutant enzymes, J. Clin. Endocrinol. Metab., 84, 4410 Nikolajeff, 1999, Spatial-mode control of vertical-cavity lasers with micromirrors fabricated and replicated in semiconductor materials, Appl. Opt., 38, 3030, 10.1364/AO.38.003030 Penning, 2000, Human 3 α -hydroxysteroid dehydrogenase isoforms (AKR1C1-AKR1C4) of the aldo-keto reductase superfamily: functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormones, Biochem J., 351, 67, 10.1042/0264-6021:3510067 Penning, 2004, Structure-function of human 3a-hydroxysteroid dehydrogenases: genes and proteins, Mol. Cell. Endocrinol., 215, 63, 10.1016/j.mce.2003.11.006 Penning, 1996, Mammalian 3 α -hydroxysteroid dehydrogenases, Steroids, 61, 508, 10.1016/S0039-128X(96)00093-1 Renfree, 1995, The marsupial male: a role model for sexual development, Philos. Trans. R. Soc. Lond. B Biol. Sci., 350, 243, 10.1098/rstb.1995.0158 Rheaume, 1992, Congenital adrenal hyperplasia due to point mutations in the type II 3 beta-hydroxysteroid dehydrogenase gene, Nat. Genet., 1, 239, 10.1038/ng0792-239 Rizner, 2003, Human type 3 3 α -hydroxysteroid dehydrogenase (aldo-keto reductase 1C2) and androgen metabolism in prostate cells, Endocrinology, 144, 2922, 10.1210/en.2002-0032 Russell, 1994, Steroid 5 α -reductase: two genes, two enzymes, Ann. Rev. Biochem., 63, 25, 10.1146/annurev.bi.63.070194.000325 Steckelbroeck, 2004, Human cytosolic 3 α -hydroxysteroid dehydrogenases of the aldo-keto reductase superfamily display significant 3β-hydroxysteroid dehydrogenase activity: implications for steroid hormone metabolism and action, J. Biol. Chem., 279, 10784, 10.1074/jbc.M313308200 Tajima, 2001, Heterozygous mutation in the cholesterol side chain cleavage enzyme (p450scc) gene in a patient with 46, XY sex reversal and adrenal insufficiency, J. Clin. Endocrinol. Metab., 86, 3820, 10.1210/jcem.86.8.7748 Thigpen, 1993, Tissue distribution and ontogeny of steroid 5 alpha-reductase isozyme expression, J. Clin. Invest., 92, 903, 10.1172/JCI116665 Voutilainen, 1986, Developmental expression of genes for the stereoidogenic enzymes P450scc (20,22-desmolase), P450c17 (17 alpha-hydroxylase/17,20-lyase), and P450c21 (21-hydroxylase) in the human fetus, J. Clin. Endocrinol. Metab., 63, 1145, 10.1210/jcem-63-5-1145 Wilson, 1981, The hormonal control of sexual development, Science, 211, 1278, 10.1126/science.7010602 Wilson, 1994, Steroid 5 α -reductase 2 deficiency, Endocr. Rev., 14, 577 Wilson, 2002, The marsupial model for male phenotypic development, Trends Endocrinol. Metab., 13, 78, 10.1016/S1043-2760(01)00525-2 Wilson, 2003, 5 α -androstane-3 α,17 β -diol is formed in tammar wallaby pouch young testes by a pathway involving 5 α -pregnane-3 α,17 β -diol-20-one as a key intermediate, Endocrinology, 144, 575, 10.1210/en.2002-220721 Zachmann, 1972, Steroid 17,20-desmolase deficiency: a new cause of male pseudohermaphroditism, Clin. Endocrinol. (Oxf), 1, 369, 10.1111/j.1365-2265.1972.tb00407.x